A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis

Table 2 Selected hematologic and biochemical parameters of FCGS patients prior to and after ASC therapy

Parameters		Non-responders (n = 5)			Responders (n = 13)			p value
Parameters	Time point	Mean	SD	Range	Mean	SD	Range	p value
White blood cell count (/μl)	Pre-treatment	10,948	1659	8740–12,340	13,807	7410	3900–28,080	0.53
	3 months	8980	4158	5530–13,597	12,284	5966	6200–28,300	0.05*
	6 months	13,667	1527	11,230–15,270	13,652	6713	6700–29,400	0.90
Lymphocyte count (/μl)	Pre-treatment	2597	643.9	1713–3122	1969	970.5	741–3973	0.23
	3 months	2082	634.8	1466–2734	1986	1161	926–5452	0.19
	6 months	2870	1018	1771–3780	2308	1676	986–6582	0.18
Neutrophil count (/μl)	Pre-treatment	7254	1223	6092–8724	10,422	6878	2145–22,717	0.61
	3 months	5326	4070	2544–9998	8831	5923	2820–24,338	0.08
	6 months	9598	2724	7705–12,720	10,398	6859	3021–26,372	0.75
Total protein (g/dl)	Pre-treatment	9.45	0.6856	8.5–10	8.462	0.76	7.3–9.5	0.10
	3 months	9.6	1.127	8.3–10.3	8.6	0.6015	7.6–9.4	0.05*
	6 months	9.233	0.7572	8.7–10.1	8.36	0.6931	7.5–9.4	0.16
Albumin (g/dl)	Pre-treatment	2.925	0.1708	2.7–3.1	3.108	0.5664	2.3–4.1	0.71
	3 months	2.667	0.3215	2.3–2.9	2.867	0.3339	2.4–3.6	0.99
	6 months	2.5	0.2646	2.2–2.7	3	0.3742	2.4–3.7	0.27

ISSN: 1757-6512